The symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of monitoring and supporting children with early-stage T1D, as well as the combined screening for both T1D and celiac disease. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.
Target Audience: Healthcare professionals including MD, DO, nurses, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies. Open to all Anschutz Medical Campus faculty and staff.
Learning Objectives:
- Review the significance of early detection and intervention for T1D
- Explain islet autoimmunity screening methods
- Explain the process of positive screening result confirmation
- Discuss the role of clinical trials and FDA-approved interventions in delaying onset of symptomatic T1D
- Collaborate with interdisciplinary teams to outline a comprehensive care plan for high-risk individuals
Registration is required for all attendees whether virtual or in-person. The 7th Symposium on General Population Screening for T1D will be held in person at the Anschutz Health Sciences Building (AHSB) located at 1890 N Revere Ct, Aurora, CO 80045. Learn more and register for the event.